Chairman Williams, Ranking Member Velázquez, and distinguished members of the U.S. House of Representatives Committee on Small Business: My name is Brian Miller, and I practice hospital medicine at the Johns Hopkins Hospital. As an academic health policy analyst, I serve as an Assistant Professor of Medicine and Business (Courtesy) at the Johns Hopkins University School of Medicine and as a Nonresident Fellow at the American Enterprise Institute. My research focuses on how we can build a more competitive and vibrant health sector to make healthcare more flexible and personalized for patients. This perspective is based upon my prior regulatory experience at four federal regulatory agencies, including the U.S. Food & Drug Administration where I worked in policy and as a reviewer in the Center for Drug Evaluation and Research’s Office of New Drugs. Through my current role as a faculty member, I regularly engage with regulators, policymakers, and businesses in search of solutions to help create a better healthcare system for all. Today I am here in my personal capacity, and the views expressed are my own and do not necessarily reflect those of the Johns Hopkins University, the American Enterprise Institute, or the Medicare Payment Advisory Commission. In my testimony today, I will focus on: Why Pharmaceutical Product Innovation Matters to Patients and Physicians Historical Actions to Address FDA Barriers to Innovation FDA Reform to Promote Pharmaceutical Product Innovation for Small Companies Read the Full Testimony Here
Authors
- Published in
- United States of America
